Corline Biomedical AB (CLBIO.ST)
CLBIO.ST Stock Price Chart
Explore Corline Biomedical AB interactive price chart. Choose custom timeframes to analyze CLBIO.ST price movements and trends.
CLBIO.ST Company Profile
Discover essential business fundamentals and corporate details for Corline Biomedical AB (CLBIO.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Jun 2015
Employees
13.00
Website
https://www.corline.seCEO
Henrik Nittmar
Description
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.
CLBIO.ST Financial Timeline
Browse a chronological timeline of Corline Biomedical AB corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 16 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 26 Aug 2025
Revenue for the quarter reached kr 2.20M , missing expectations by -62.71%.
Earnings released on 8 May 2025
EPS came in at -kr 0.13 , while revenue for the quarter reached kr 2.06M , missing expectations by -41.29%.
Earnings released on 17 Feb 2025
EPS came in at -kr 0.62 , while revenue for the quarter reached kr 2.01M , missing expectations by -49.70%.
Earnings released on 7 Nov 2024
EPS came in at -kr 0.14 , while revenue for the quarter reached kr 1.77M .
Earnings released on 23 Aug 2024
EPS came in at -kr 0.20 , while revenue for the quarter reached kr 2.26M .
Earnings released on 30 Apr 2024
EPS came in at -kr 0.08 , while revenue for the quarter reached kr 3.74M .
Earnings released on 14 Feb 2024
EPS came in at -kr 0.03 , while revenue for the quarter reached kr 6.24M .
Earnings released on 10 Nov 2023
EPS came in at kr 0.01 , while revenue for the quarter reached kr 5.31M .
Earnings released on 25 Aug 2023
EPS came in at -kr 0.11 , while revenue for the quarter reached kr 6.08M .
Earnings released on 28 Apr 2023
EPS came in at kr 0.05 , while revenue for the quarter reached kr 7.40M .
Earnings released on 24 Feb 2023
EPS came in at kr 0.02 , while revenue for the quarter reached kr 8.25M .
Earnings released on 25 Nov 2022
EPS came in at kr 0.09 , while revenue for the quarter reached kr 7.03M .
Earnings released on 23 Aug 2022
EPS came in at kr 0.04 , while revenue for the quarter reached kr 5.21M .
Earnings released on 9 May 2022
EPS came in at -kr 0.04 , while revenue for the quarter reached kr 3.07M .
Earnings released on 24 Feb 2022
EPS came in at -kr 0.06 , while revenue for the quarter reached kr 3.24M .
Earnings released on 25 Nov 2021
EPS came in at -kr 0.10 , while revenue for the quarter reached kr 1.33M .
Earnings released on 30 Sept 2021
EPS came in at -kr 0.10 , while revenue for the quarter reached kr 962.00K .
Earnings released on 31 Mar 2021
EPS came in at -kr 0.08 , while revenue for the quarter reached kr 1.53M .
Stock split effective on 4 Jan 2021
Shares were split 257 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2020
EPS came in at -kr 0.00 , while revenue for the quarter reached kr 2.54M .
Earnings released on 30 Sept 2020
EPS came in at -kr 0.13 , while revenue for the quarter reached kr 368.00K .
CLBIO.ST Stock Performance
Access detailed CLBIO.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.